Federal officials say a COVID-19 vaccine for Canada’s youngest children could be approved as soon as this month.
Health Canada tweeted Tuesday that it expects to reach a decision by mid-July on whether to approve Moderna’s shot for children between six months and five years old.
Moderna has applied for its vaccine to be given in two doses, each a quarter of its adult dose, given about four weeks apart.
- PHAC finds no evidence of mystery brain disease in New Brunswick, says patients still need answers
- Beer recall hits 2 more Canadian products, bringing total to 31
- Alberta expanding use of AI tech that speeds up MRIs after successful pilot
- Stopping GLP-1 drugs could increase heart attack risk for some, study says
Get weekly health news
The agency says it received a submission from Pfizer-BioNTech on June 23 for its vaccine for children between the ages of six months and four years old.
Read more: ‘COVID-19 is still out there’: New clinics in east Calgary aimed at getting more kids vaccinated
A Health Canada spokesperson says regulators are still working out a timeline for their review of Pfizer-BioNTech’s application.
Canada has yet to authorize a vaccine for its nearly two million children under five.
Pfizer-BioNTech’s Comirnaty vaccine can be used on kids as young as five, and Moderna’s Spikevax shot has been approved for children ages six and up.
Comments
Want to discuss? Please read our Commenting Policy first.